Laura Sessanna, C.N.M. Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 7370 Turfway Road, Florence, KY 41042 Phone: 859-212-5125 Fax: 859-212-5099 |
Jacqueline Christine Ganshirt, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 7370 Turfway Rd, Ste 390, Florence, KY 41042 Phone: 859-212-5125 Fax: 859-212-5099 |
Ms. Kelly Ganster, CNM ARNP Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 7370 Turfway Rd, Florence, KY 41042 Phone: 859-212-5125 Fax: 859-212-5099 |
Sara Ferguson, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 7607 Dixie Hwy, Florence, KY 41042 Phone: 859-655-6100 Fax: 859-282-8611 |
Mrs. Jennifer Lynn Dooley, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 7370 Turfway Rd, Ste 390, Florence, KY 41042 Phone: 859-212-5125 Fax: 859-212-5099 |
News Archive
PharmedOut, an initiative aimed at increasing physician access to unbiased information about drugs, will host a conference to explore the issues of pharmaceutical industry funding on continuing medical education. The conference, "Prescription for Conflict: Should Industry Fund Continuing Medical Education?" will be held June 25, 2010 at Georgetown University.
​Research presented today at the 4th Asia-Pacific Osteoporosis Meeting showed that second hip fractures are more deadly than first hip fractures. Based in Hong Kong, the study evaluated the overall incidence of a second hip fracture and subsequent mortality in 43,832 patients, aged 65 or above, with operatively treated first hip fracture during the years 2000-2011.
Australian vaccine development company BioDiem Ltd (ASX: BDM) today announced that it has begun a research collaboration with France-based VIVALIS (Euronext code: VLS), a biopharmaceutical company with expertise in vaccine production technologies.
Inovio Biomedical Corporation, a leader in the development of new preventive and therapeutic vaccines against cancers and infectious diseases, announced today that it has changed its corporate name to Inovio Pharmaceuticals, Inc. by filing a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware on May 14, 2010. Inovio's trading symbol remains the same.
› Verified 1 days ago